(Q53499534)

14 May 2018

title

Adenovirus IL-13-induced airway disease in mice: a corticosteroid-resistant model of severe asthma. (English)

1 reference

14 May 2018

0 references

1 reference

12

Hani Houshyar

1 reference

14 May 2018

author name string

Alex G Therien

1

1 reference

14 May 2018

Virginie Bernier

2

1 reference

14 May 2018

Sean Weicker

3

1 reference

14 May 2018

Paul Tawa

4

1 reference

14 May 2018

Jean-Pierre Falgueyret

5

1 reference

14 May 2018

Marie-Claude Mathieu

6

1 reference

14 May 2018

Jeanne Honsberger

7

1 reference

14 May 2018

Véronique Pomerleau

8

1 reference

14 May 2018

Annette Robichaud

9

1 reference

14 May 2018

Rino Stocco

10

1 reference

14 May 2018

Lynn Dufresne

11

1 reference

14 May 2018

Josiane Lafleur

13

1 reference

14 May 2018

Chidambaram Ramachandran

14

1 reference

14 May 2018

Gary P O'Neill

15

1 reference

14 May 2018

Deborah Slipetz

16

1 reference

14 May 2018

Christopher M Tan

17

1 reference

14 May 2018

publication date

7 February 2008

1 reference

14 May 2018

American Journal of Respiratory Cell and Molecular Biology

published in

1 reference

14 May 2018

volume

39

1 reference

14 May 2018

issue

1

1 reference

14 May 2018

page(s)

26-35

1 reference

14 May 2018

Immunologic basis of antigen-induced airway hyperresponsiveness

cites work

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

Cytokines, allergy, and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

Introduction: asthma in the new millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

Interleukin-13: central mediator of allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

Association studies for asthma and atopic diseases: a comprehensive review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

Genetics of IL-13 and functional relevance of IL-13 variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

Comparative analysis of the effects of packaging signal, transgene orientation, promoters, polyadenylation signals, and E3 region on growth properties of first-generation adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

The innate immune response to adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

Inhibition of human interleukin-13-induced respiratory and oesophageal inflammation by anti-human-interleukin-13 antibody (CAT-354).

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

Inhibition of allergic airways inflammation and airway hyperresponsiveness in mice by dexamethasone: Role of eosinophils, IL-5, eotaxin, and IL-13

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

Structure of C3b in complex with CRIg gives insights into regulation of complement activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

Inhibition of Complement Activation Decreases Airway Inflammation and Hyperresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

Respiratory infections: their role in airway responsiveness and the pathogenesis of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

Innate immunity in the pathogenesis of virus-induced asthma exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

Role of nasal interleukin-8 in neutrophil recruitment and activation in children with virus-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

Is the neutrophil the key effector cell in severe asthma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

Role of neutrophils in mucus hypersecretion in COPD and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

Airway hyperresponsiveness after endotoxin inhalation depends on leukocyte infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

Differential regulation by glucocorticoid of interleukin-13-induced eosinophilia, hyperresponsiveness, and goblet cell hyperplasia in mouse airways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

Persistent effects induced by IL-13 in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

House dust mite major allergens Der p 1 and Der p 5 activate human airway-derived epithelial cells by protease-dependent and protease-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

Proteomic analysis of differently expressed proteins in a mouse model for allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

Dexamethasone alters bronchoalveolar lavage fluid proteome in a mouse asthma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

Proteome analysis of differential protein expression in allergen-induced asthmatic mice lung after dexamethasone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

Proteome analysis of bronchoalveolar lavage in lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

Expression of the Ym2 lectin-binding protein is dependent on interleukin (IL)-4 and IL-13 signal transduction: identification of a novel allergy-associated protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

Association of uteroglobulin-related protein 1 with bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

Characterization of a calcium-activated chloride channel as a shared target of Th2 cytokine pathways and its potential involvement in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

Influence of inflammatory mechanisms on the redox balance in interstitial lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

IL-13 results in differential regulation of the complement proteins C3 and factor B in tumour necrosis factor (TNF)-stimulated fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

A role for the C3a anaphylatoxin receptor in the effector phase of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0240OC

21 January 2018

Identifiers

DOI

10.1165/RCMB.2007-0240OC

1 reference

14 May 2018

1 reference

14 May 2018